Received Sep 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 3 | — | — |
patient had completed the full quadrivalent HPV vaccination, administered at ages 16, 18, and 19 (she completed the full series); This literature report has been received from the authors of the published article and refers to a 18-year-old female patient (at the report time was 26-year-old). The patient's medical history included chronic tonsillitis. The patient's concurrent conditions included human papillomavirus (HPV)-associated pathology. Concomitant therapies were not reported. On an unknown date at the age of 16, the patient was vaccinated with Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine, dose number 1, (lot # and expiration date were not reported). On an unknown date at the age of 18, the patient was vaccinated with Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine, dose number 2, (lot # and expiration date were not reported). On an unknown date at the age of 19, the patient was vaccinated with Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine, dose number 3, (lot # and expiration date were not reported) as a prophylaxis. Therefore, the patient had completed the full quadrivalent HPV vaccination, administered at ages 16, 18, and 19 (she completed the full series) (Inappropriate schedule of product administration). A copy of the published article is attached as further documentation of the patient's experience. Literature report:
Human papilloma virus infection
Medical History/Concurrent Conditions: Chronic tonsillitis (underwent tonsillectomy)